[HTML][HTML] SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness

A Sheikh, J McMenamin, B Taylor, C Robertson - The Lancet, 2021 - thelancet.com
On May 19, 2021, the Delta Variant of Concern (VOC), formerly known as the Indian VOC or
B 1.617. 2, became the dominant strain of SARS-CoV-2 in Scotland. The Alpha VOC (…

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England …

…, K Brown, C Cameron, D Stockton, J McMenamin… - bmj, 2021 - bmj.com
Objective To estimate the real world effectiveness of the Pfizer-BioNTech BNT162b2 and
Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms (including the …

[HTML][HTML] Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

…, J Marple, C McCowan, D McGagh, J McMenamin… - The Lancet, 2021 - thelancet.com
Background The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca)
COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical …

[HTML][HTML] First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

…, S Bedston, M O'Leary, A Akbari, J McMenamin… - Nature medicine, 2021 - nature.com
Reports of ChAdOx1 vaccine–associated thrombocytopenia and vascular adverse events
have led to some countries restricting its use. Using a national prospective cohort, we …

[HTML][HTML] Effect of vaccination on transmission of SARS-CoV-2

…, R Wood, M Reid, J McMenamin… - … England Journal of …, 2021 - Mass Medical Soc
Effect of Vaccination on Transmission of SARS-CoV-2 | NEJM Skip to main content NEJM
Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …

[HTML][HTML] Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland

…, S Philip, A Collier, J McMenamin… - The lancet Diabetes & …, 2021 - thelancet.com
Background We aimed to ascertain the cumulative risk of fatal or critical care unit-treated
COVID-19 in people with diabetes and compare it with that of people without diabetes, and to …

[HTML][HTML] Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with …

…, S Kerr, M Woolhouse, J McMenamin… - The Lancet Infectious …, 2022 - thelancet.com
Background Since its emergence in November, 2021, in southern Africa, the SARS-CoV-2
omicron variant of concern (VOC) has rapidly spread across the world. We aimed to …

Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and …

…, K Brown, C Cameron, D Stockton, J McMenamin… - MedRxiv, 2021 - medrxiv.org
Objectives To estimate the real-world effectiveness of the Pfizer/BioNTech BNT162b2 vaccine
and Astrazeneca ChAdOx1 vaccine against Confirmed COVID-19, hospitalisations and …

[HTML][HTML] Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study …

…, U Agrawal, AB Docherty, C McCowan, J McMenamin… - The Lancet, 2022 - thelancet.com
Background Reports suggest that COVID-19 vaccine effectiveness is decreasing, but whether
this reflects waning or new SARS-CoV-2 variants—especially delta (B.1.617.2)—is unclear…

Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study

…, M Reid, A Smith-Palmer, D Goldberg, J McMenamin… - bmj, 2020 - bmj.com
Objective To assess the risk of hospital admission for coronavirus disease 2019 (covid-19)
among patient facing and non-patient facing healthcare workers and their household …